# Silence Therapeutics plc: Form D filings

Silence Therapeutics plc, a biotechnology company in London, United Kingdom, filed 4 Form D notices with the SEC between 2010 and 2021. The latest, on February 18, 2021, reports $45.5 million sold of a $45.5 million offering to 12 investors.

Find out what Silence Therapeutics plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Silence%20Therapeutics%20plc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Silence%20Therapeutics%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fsilence-therapeutics-plc-1479615)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Silence%20Therapeutics%20plc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Silence%20Therapeutics%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fsilence-therapeutics-plc-1479615)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 72 HAMMERSMITH ROAD, London, United Kingdom, W14 8
- Phone: 44-0-20-3457 6900
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: United Kingdom
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1479615

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 18, 2021 | New notice | $45,499,905 | $45,499,905 | $0 | 12 | Feb 4, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1479615/000123191921000018/0001231919-21-000018-index.htm) |
| Jan 5, 2010 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1479615/000147961510000003/0001479615-10-000003-index.htm) |
| Jan 5, 2010 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1479615/000147961510000002/0001479615-10-000002-index.htm) |
| Jan 5, 2010 | New notice | $8,500,000 | $0 | $8,500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1479615/000147961510000001/0001479615-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James Ede-Golightly | Director |  |
| Alistair Gray | Director |  |
| Craig Tooman | Executive Officer |  |
| Dave Lemus | Director |  |
| Giles Campion | Executive Officer |  |
| Romano Steven | Director |  |
| Michael H. Davidson | Director |  |
| Mark Rothera | Executive Officer, Director |  |
| Iain Ross | Director |  |
| Barbara Ruskin | Executive Officer |  |

[Every Form D from the week of Feb 15, 2021](https://specstream.ai/data/form-d/week/2021-02-15) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Silence Therapeutics plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).